Glucose Monitoring in Youth With Cystic Fibrosis During Pulmonary Exacerbations

NCT06546943 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2024-08-09

No results posted yet for this study

Summary

The goal of this study is to investigate the prevalence of dysglycemia with continuous glucose monitoring (CGM) obtained during pulmonary exacerbations, both outpatient and inpatient, in youth with cystic fibrosis (CF).

Conditions

  • Cystic Fibrosis Pulmonary Exacerbation

Sponsors & Collaborators

  • Cystic Fibrosis Foundation

    collaborator OTHER
  • Baylor College of Medicine

    collaborator OTHER
  • University of Colorado, Denver

    lead OTHER

Eligibility

Min Age
6 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-04
Primary Completion
2025-04-30
Completion
2025-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06546943 on ClinicalTrials.gov